Anti-inflammatory and immunosuppressive drugs and reproduction.
Arthritis Research & Therapy2006Vol. 8(3), pp. 209–209
Citations Over TimeTop 1% of 2006 papers
Monika Østensen, Munther A. Khamashta, Michael D. Lockshin, Ann L. Parke, Antonio Brucato, Howard Carp, Andrea Doria, Raj Rai, Pier Luigi Meroni, Irene Cetin, Ronald H. W. M. Derksen, Ware Branch, Mario Motta, Caroline Gordon, Guillermo Ruiz‐Irastorza, Arsenio Spinillo, Deborah Friedman, Rolando Cimaz, Andrew E. Czeizel, Jean Charles Piette, Ricard Cervera, Roger A. Levy, Maurizio Clementi, Sara De Carolis, Michelle Petri, Yehuda Shoenfeld, David Faden, Guido Valesini, Anǵela Tincani
Abstract
Rheumatic diseases in women of childbearing years may necessitate drug treatment during a pregnancy, to control maternal disease activity and to ensure a successful pregnancy outcome. This survey is based on a consensus workshop of international experts discussing effects of anti-inflammatory, immunosuppressive and biological drugs during pregnancy and lactation. In addition, effects of these drugs on male and female fertility and possible long-term effects on infants exposed to drugs antenatally are discussed where data were available. Recommendations for drug treatment during pregnancy and lactation are given.
Related Papers
- → Advances in non-biological drugs for the treatment of rheumatoid arthritis(2023)12 cited
- → Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010(2018)7 cited
- → The teratogenicity of antirheumatic drugs—what is the evidence?(1998)23 cited
- → Biological disease‐modifying drugs for rheumatoid arthritis(2020)1 cited
- → Profile of Patients with Rheumatoid Arthritis: a Descriptive Analysis(2022)